Buscar

04/04/2025 Design and Validation of a Simplified Method to Determine Minimum Bactericidal Concentration in Nontuberculous Mycobacteria
Batista, S, Fernandez-Pittol, M, San Nicolás, L, Martínez, D, Narváez, S, Espasa, M, Losilla, EG, Rubio, M, Garrigo, M, Tudó, G, González-Martin, J. Design and Validation of a Simplified Method to Determine Minimum Bactericidal Concentration in Nontuberculous Mycobacteria. Antibiotics-Basel. 2025; 14(4)DOI:10.3390/antibiotics14040381. PMID:40298560. IF:4.600(Q1/2D).
01/04/2025 Whole Genome Sequencing Analysis of Klebsiella pneumoniae Isolates from Health Care-Associated Bacteremia of Urinary Origin in Spain: Findings from the Multicenter ITUBRAS-2 Cohort Study
Becerra-Aparicio, F, Gómez-Zorrilla, S, Hernández-García, M, Xanthopoulou, K, Gijón, D, Siverio, A, Berbel, D, Cercenado, E, Rivera, A, De Malet, A, Xercavins, M, De Gopegui, ER, Canoura-Fernández, L, Martínez, JA, Seral, C, Del Pozo, JL, Cotarelo, M, Ponz, R, Higgins, PG, Durán-Jordà, X, Cantón, R, Oliver, A, Horcajada, JP, Ruiz-Garbajosa, P. Whole Genome Sequencing Analysis of Klebsiella pneumoniae Isolates from Health Care-Associated Bacteremia of Urinary Origin in Spain: Findings from the Multicenter ITUBRAS-2 Cohort Study. Open Forum Infectious Diseases. 2025; 12(4)DOI:10.1093/ofid/ofaf164. PMID:40201725. IF:3.800(Q1/3D).
11/03/2025 Non-tuberculous mycobacteria isolates from patients with chronic pulmonary disease and no epidemiological relationship show sequence clusters through whole-genome sequencing
Rubio, M, Fernandez-Pittol, M, Batista, S, Martínez, D, San Nicolas, L, Portell-Buj, E, Busquets, MA, Estelrich, J, Gonzalez-Martin, J, Navarro, F, Tudó, G, Garrigó, M. Non-tuberculous mycobacteria isolates from patients with chronic pulmonary disease and no epidemiological relationship show sequence clusters through whole-genome sequencing. Frontiers in Microbiology. 2025; 16DOI:10.3389/fmicb.2025.1549030. PMID:40135059. IF:4.500(Q1/3D).
01/02/2025 Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: a prospective multicenter study
Mancheño-Losa, M, Murillo, O, Benavent, E, Sorlí, L, Riera, M, Cobo, J, Benito, N, Morata, L, Ribera, A, Sobrino, B, Fernández-Sampedro, M, Múñez, E, Bahamonde, A, Barbero, JM, del Toro, MD, Villa, J, Rigo-Bonnin, R, Luque, S, García-Luque, I, Oliver, A, Esteban, J, Lora-Tamayo, J. Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: a prospective multicenter study. INFECTION. 2025; 53(1)DOI:10.1007/s15010-024-02379-7. PMID:39249177. IF:3.600(Q2/3D).
01/01/2025 Real-World Experience of Imipenem-Relebactam Treatment as Salvage Therapy in Difficult-to-Treat Pseudomonas aeruginosa Infections (IMRECOR Study)
Machuca, I, Dominguez, A, Amaya, R, Arjona, C, Gracia-Ahufinger, I, Carralon, M, Giron, R, Gea, I, De Benito, N, Martin, A, Galan, F, Martinez, JA, Iglesias, R, Revuelto, J, Caston, JJ, Cano, A, Ruiz-Arabi, E, Martínez-Martínez, L, Torre-Cisneros, J. Real-World Experience of Imipenem-Relebactam Treatment as Salvage Therapy in Difficult-to-Treat Pseudomonas aeruginosa Infections (IMRECOR Study). Infectious Diseases and Therapy. 2025; 14(1)DOI:10.1007/s40121-024-01077-z. PMID:39612160. IF:5.300(Q1/2D).
01/01/2025 Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria (vol 13, 874, 2024)
Kirkegaard-Biosca, C, del Barrio-Tofiño, E, Villamarín, M, Larrosa, N, Campany, D, González-López, JJ, Ferrer, R, Viñado, B, Doménech, L, Sellarès-Nadal, J, Escolà-Vergé, L, Fernández-Hidalgo, N, Los-Arcos, I. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria (vol 13, 874, 2024). Antibiotics-Basel. 2025; 14(1)DOI:10.3390/antibiotics14010004. PMID:39858394. IF:4.600(Q1/2D).
01/12/2024 Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update
Ruiz-Arabi, E, Torre-Cisneros, J, Aguilera, V, Alonso, R, Berenguer, M, Bestard, O, Bodro, M, Cantisan, S, Carratalà, J, Castón, JJ, Cordero, E, Facundo, C, Fariñas, MC, Fernández-Alonso, M, Fernández-Ruiz, M, Fortún, J, García-Cosío, MD, Herrera, S, Iturbe-Fernández, D, Len, O, López-Medrano, F, López-Oliva, MO, Los-Arcos, I, Marcos, MA, Martín-Dávila, P, Monforte, V, Muñoz, P, Navarro, D, Páez-Vega, A, Pérez, AB, Redondo, N, Alvarez, RR, Rodríguez-Benot, A, Rodríguez-Goncer, I, San-Juan, R, Sánchez-Céspedes, J, Valerio, M, Vaquero, JM, Viasus, D, Vidal, E, Aguado, JM. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update. Transplantation Reviews. 2024; 38(4)DOI:10.1016/j.trre.2024.100875. PMID:39168020. IF:2.500(Q1/1D).
01/12/2024 Efficacy and safety of antistaphylococcal penicillin or cephazolin-based combinations versus monotherapy for methicillin-susceptible Staphylococcus aureus infective endocarditis: A propensity score analysis of nationwide prospective cohort
Calderón-Parra, J, Grillo, S, Muñoz, P, Machado-Vilchez, M, Delgado-Montero, A, De Alarcón-González, A, Poyato-Borrego, M, Goenaga-Sánchez, M, Fariñas-Alvarez, MC, Miró, JM, López-Cortés, LE, Rodríguez-García, R, Oteo, JA, Martínez-Ramos, A. Efficacy and safety of antistaphylococcal penicillin or cephazolin-based combinations versus monotherapy for methicillin-susceptible Staphylococcus aureus infective endocarditis: A propensity score analysis of nationwide prospective cohort. JOURNAL OF INFECTION. 2024; 89(6)DOI:10.1016/j.jinf.2024.106352. PMID:39561880. IF:11.900(Q1/1D).